11 patents currently held
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jun 2034. from the record
Of the 3 now held by other companies, 2 name Jins Holdings Inc. as their current owner, and 1 more name another party. Each row says which.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Jun 2034
Next term end
9
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2035 · High confidence
Also notable
Ends Jan 2037 · High confidence
Also notable
Ends Dec 2037 · High confidence
Myopia Prevention Device
US 10,133,092
The most cited patent in this portfolio, cited by 59 later US patents, top 5% of utility patents granted in 2018 in our data. Protection runs to 2035.
Light Source for Myopia Prevention Article and Method of Using Light Source for Myopia Prevention Article
US 11,007,375
Cited by 7 later US patents, top 25% of utility patents granted in 2021 in our data. Protection runs to 2037.
Display System, Electronic Device, and Lighting System
US 10,660,182
Granted 2020. Computed term ends 2037.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 14, 2027The maintenance fee for Composition and Functional Food for Preventing Myopia (US 11,813,299) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 19, 2026
What they patent
The 5 largest of its 9 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Light Source for Myopia Prevention Article and Method of Using Light Source for Myopia Prevention Article | 2 in force | to Jul 2038 |
| Myopia Prevention Device | 2 in force | to Jun 2035 |
| Prophylactic Agent, Ameliorating Agent, and Therapeutic Agent for Dry Eye | 1 in force | to Apr 2043 |
| Agent for Adjusting Hardness of Lens of Eye | 1 in force | to Nov 2041 |
| Mouse Myopia-Induced Model and Endoplasmic Reticulum Stress Suppressant for Preventing and Suppressing Myopia | 1 in force | to Aug 2040 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,877,975 | Agent for Treating Meibomian Gland Dysfunction In force · High confidence | In force | High confidence | |
| US 10,133,092 | Myopia Prevention Device In force · High confidence | In force | High confidence | |
| US 10,823,982 | Myopia Treatment Device In force · High confidence | In force | High confidence | |
| US 11,007,375 | Light Source for Myopia Prevention Article and Method of Using Light Source for Myopia Prevention Article held by Toshiba Materials Co., Ltd. and Tsubota Laboratory, Inc. In force · High confidence | In force | High confidence | |
| US 10,660,182 | Display System, Electronic Device, and Lighting System In force · High confidence | In force | High confidence | |
| US 11,813,299 | Composition and Functional Food for Preventing Myopia In force · High confidence | In force | High confidence | |
| US 12,023,513 | Light Source for Myopia Prevention Article and Method of Using Light Source for Myopia Prevention Article held by Toshiba Materials Co., Ltd. In force · High confidence | In force | High confidence | |
| US D1,067,314 | Temple for eyeglasses held by Jins Holdings Inc. and Tsubota Laboratory, Inc. In force · High confidence | In force | High confidence | |
| US 12,478,597 | Mouse Myopia-Induced Model and Endoplasmic Reticulum Stress Suppressant for Preventing and Suppressing Myopia In force · High confidence | In force | High confidence | |
| US 12,758,568 | Agent for Adjusting Hardness of Lens of Eye In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 11: 3 patents in force now held by others · 21 applications pending · 9 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.